Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · IEX Real-Time Price · USD
53.29
-0.96 (-1.77%)
At close: May 17, 2024, 4:00 PM
53.28
-0.01 (-0.02%)
After-hours: May 17, 2024, 4:00 PM EDT
Immunocore Holdings Employees
Immunocore Holdings had 497 employees on December 31, 2023. The number of employees increased by 89 or 21.81% compared to the previous year.
Employees
497
Change (1Y)
89
Growth (1Y)
21.81%
Revenue / Employee
$531,698
Profits / Employee
-$118,414
Market Cap
2.67B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 497 | 89 | 21.81% |
Dec 31, 2022 | 408 | 84 | 25.93% |
Dec 31, 2021 | 324 | 33 | 11.34% |
Dec 31, 2020 | 291 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Bausch Health Companies | 20,270 |
Evolent Health | 4,700 |
Azenta | 3,500 |
Inari Medical | 1,300 |
Twist Bioscience | 919 |
TG Therapeutics | 264 |
Merus | 229 |
Celldex Therapeutics | 160 |
IMCR News
- 10 days ago - Immunocore reports first quarter financial results and provides a business update - GlobeNewsWire
- 24 days ago - Immunocore announces upcoming presentation and posters at ASCO 2024 - GlobeNewsWire
- 6 weeks ago - Immunocore to present at upcoming investor conferences - GlobeNewsWire
- 2 months ago - Immunocore presented two posters at CROI 2024 - GlobeNewsWire
- 2 months ago - Immunocore reports fourth quarter and full year 2023 financial results and provides a business update - GlobeNewsWire
- 3 months ago - Immunocore announces clinical trial collaboration and supply agreement with Bristol Myers Squibb to evaluate IMC-F106C (PRAME HLA-A02) in combination with nivolumab in its registrational Phase 3 first-line advanced cutaneous melanoma trial - GlobeNewsWire
- 3 months ago - Immunocore to report fourth quarter and full year 2023 financial results and host call on February 28, 2024 - GlobeNewsWire
- 3 months ago - Immunocore Prices Upsized Convertible Senior Notes Offering - GlobeNewsWire